Emerging targets in the long QT syndromes and Brugada syndrome

Author： Towbin J.A. Vatta M. Wang Z. Bowles N.E. Li H.

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.3, Iss.3, 1999-09, pp. : 423-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disorders

By Nemec J. Shen W-K.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 773-797

Informa Healthcare

Access to resources Recommend Favorite

Potassium in Long QT Syndromes

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 51-53

Karger

Access to resources Recommend Favorite

Specific Therapy Based on the Genotype and Cellular Mechanism in Inherited Cardiac Arrhythmias. Long QT Syndrome and Brugada Syndrome

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-01 ,pp. : 1561-1572

Bentham Science Publishers

Access to resources Recommend Favorite

Medical Therapy for Long QT Syndrome

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 6, 2018-03 ,pp. : 495-506

Bentham Science Publishers

Access to resources Recommend Favorite

Measure of the QT–RR Dynamic Coupling in Patients with the Long QT Syndrome

By Halamek Josef Couderc Jean-Philippe Jurak Pavel Vondra Vlastimil Zareba Wojciech Viscor Ivo Leinveber M.Sc. Pavel

Annals of Noninvasive Electrocardiology, Vol. 17, Iss. 4, 2012-10 ,pp. : 323-330

Blackwell Publishing

Access to resources Recommend Favorite